Sinopep-Allsino Bio Pharmaceutical (688076.SS) Earnings Analysis

Sinopep-Allsino Bio Pharmaceutical (688076.SS) next reports earnings on 2026-08-20. It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E 27.55.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 688076.SS next report earnings?

Next earnings date2026-08-20
Consensus EPS estimaten/a
Revenue estimate0.50B

688076.SS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-27-0.37 CNYn/an/an/a
2025-10-220.4255 CNYn/an/an/a
2025-02-270.2438 CNY0.2929 CNY-16.8%Miss
2024-08-220.699 CNY0.1 CNY+599%Beat

Beat rate: 1/2 (50%) over reported quarters with consensus data.

688076.SS valuation and analyst view

Trailing P/E27.55
Trailing EPS0.96138 CNY
Price / book2.71
Dividend yield1.31%
Market cap8.51B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Sinopep-Allsino Bio Pharmaceutical (688076.SS)'s next earnings date?

Sinopep-Allsino Bio Pharmaceutical is next scheduled to report on 2026-08-20 and revenue estimate of 0.50B.

Did 688076.SS beat earnings last quarter?

Consensus estimate data was not available for 688076.SS's 2026-02-27 report.

What is 688076.SS's earnings track record?

Over the last 2 reported quarters with consensus data, 688076.SS beat estimates 1 times (50%).

What is 688076.SS's current P/E ratio and EPS?

688076.SS trades at a trailing P/E of 27.55 on trailing EPS of 0.9613825162390973 CNY.

What do analysts rate 688076.SS?

688076.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.